{"name":"Jacobio Pharmaceuticals Co., Ltd.","slug":"jacobio-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-02","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQak9WbS1GQ3JuTDJjbGMyX3dEdjVmc09JTVFfc3g3WGJYX1NZY183RVhoR0xCTlVROVNWd0UtNlAwMzZUb09lZEk2bXEtd3lzNWU5bG9kQnE3ZlFLRFM1UGNDMU1ubVJqcWVuVUhjYkhtdjQ1UFQ4SkNfcXJ3WjRHNm04c0pCYjVKMGFaWUtKSkloaVJRcjZWMlpneEJYNkNVZmhYZlFpYUVKSzdvX0JYTllESDJZdF9HQ1E?oc=5","date":"2026-03-19","type":"earnings","source":"Sahm","summary":"Jacobio Pharma Poised To Turn A Profit From Precision Cancer Drugs - Sahm","headline":"Jacobio Pharma Poised To Turn A Profit From Precision Cancer Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPdTY0Ym9ENlhVc2xKYTZaM0E1VDRoQWFURC1lMGdzbWoxZFIxXzhIcC1Leld6Q3VDS09VTlktNUR0ZUY5eTRRbmdOcHlMME1tZWQ1aEIzcUNzaG1sTzJoWGtzWl9WZ19scVRkd3hCVnc0YVl4akpyXzY0QkdYMTYtT2dGZ0FKb2xWdXVwZ2owYVBOWVZnOEhpNDVEV0NjY1V4a0dpNW9hWm8yR3o1ckRfNEhkR1pPOG5fV0ZEM3BrRG1aQ0NucFBwS2RHSGxGS0M3XzdJOFpZVXlQMHF5M1doUkVTcUl1M3hPZ3FhTk1pRXhmaHFBWnBUc2RxT0k1SEUz?oc=5","date":"2026-03-16","type":"deal","source":"The Globe and Mail","summary":"Huachuang Securities Sticks to Its Buy Rating for Jacobio Pharmaceuticals Group Co., Ltd. (1167) - The Globe and Mail","headline":"Huachuang Securities Sticks to Its Buy Rating for Jacobio Pharmaceuticals Group Co., Ltd. (1167)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE0xQnJ6RHhvTU9HWWFsZ1lUMHJwblY5WGh1dFFRTktEaFMwZXhNdk9VZkhRQUJmM2hhVVJaWTktTmhKYXVUSXp3T19tNjBzbHdLbDFYdlNVRkhLS29tVkc1YTY0Y3Q1Q2lNVk9vYndudmE5NWNoek5JS2cwYk0tUQ?oc=5","date":"2026-03-11","type":"pipeline","source":"China Daily","summary":"Chinese biotech innovator Jacobio Pharma reports its 2025 annual results - China Daily","headline":"Chinese biotech innovator Jacobio Pharma reports its 2025 annual results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQaWFGSXRIZGRjRWE4YVRTT0FiT1VBYUxscm9abWRLc0w5bmZGUzZfQ0U3Q3dlOVI1aFZlQ3BEY2J4MUlzeUtGNzRBeGhXUUc5TVYzT2R3ZWxqLWFzSElDYmI1VzBFN216SG5OMW5VRHpuUmVYcUN6QU43dHhuREtabEV0dlZ0cWJhU1I4?oc=5","date":"2026-01-12","type":"deal","source":"Law.asia","summary":"Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca - Law.asia","headline":"Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbU9jTk95eDBQTkpiMi1QQVBlOHhJOHBDMjRvQ2pSWkx1b3dXZ0ZackZLZW83amZCd0MzbDlwY2t4VTZsYVBVdWt2RnhVdHJiekcyeFcyd2lmZDV1NF8wbEttN0dFdHU0VEJUenhZdDZPT3ozR0Jac1loUW9Xa2s0NDUtZldYeDdmZ1VELUUyWk4zdmtZdFktb1RJb2FyR1FVX3Z1UmgxUHVYTmFxeWVscHZpWFlmM1lUMVZoSnI0Uk4?oc=5","date":"2025-12-24","type":"deal","source":"Caixin Global","summary":"Jacobio Pharma Signs $2 Billion Deal With AstraZeneca for Cancer Drug - Caixin Global","headline":"Jacobio Pharma Signs $2 Billion Deal With AstraZeneca for Cancer Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNcDRUdktlWHljR3FtVlNOT3JHS2gtMzNMaXNuQzBBX3ctNjdyd21hNzE3TFhrb2xFVkVLd3lzRXhhYUlCNk1CVkRhQ2twdWdnRkNJYXRxa1ZwOWNqMGZ0UUp0WjZpTkoyNzRWeVZWTnZRSk05S3dhdmZwTmVRQ2tFNFpKNTRZMjVDd2xIVHdOWks2Sl9hU2l3NjZhTXNYSzBxREhwMEtUOA?oc=5","date":"2025-12-22","type":"pipeline","source":"fiercebiotech.com","summary":"AstraZeneca fronts $100M for Jacobio's clinical-stage pan-KRAS inhibitor - fiercebiotech.com","headline":"AstraZeneca fronts $100M for Jacobio's clinical-stage pan-KRAS inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQZ1hYMG12cUc1cFYyOGxyWHRjTUlkTlR2SVBwTy1RY1FpRlAtOUhzRHZkUzlheTFLOGxaSEtQVXc2VGRnOWh5aGJCQVlQTG15QUhQQm9iNUIyREsyQzA0d1VoUlRsTzdZeTA3cHF6YzY4cUJNeDAyMXNzejNJX0xkSVlkY1lYUXRXdDljMmh1Y2VFZ2VUTUd5aFdMTFJBUHVYRGU2blEtRnBYYWxM?oc=5","date":"2025-12-22","type":"deal","source":"Bloomberg.com","summary":"Watch Jacobio Strikes New Cancer Drug Deal with AstraZeneca - Bloomberg.com","headline":"Watch Jacobio Strikes New Cancer Drug Deal with AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPYmppUmNCLW83Rm9rWW1XaXV0dDVMb1Q2elY4V09IS2s2X0tMM09WVEx4VmFsbUlSS3FTWVVMQ2ZzamVOVHZnVkZ5TEoxNmI0dmhuWGIzblRDdFVBUTFyUVo2MUhkQ1Q4bnNyanlmLVcxaGdMT0JvZGlMd1l1R1RMNHhib1VmU0pvTjZmN1JnZFVMYU5ZalhEdld0N25tTXA5dDJ6OTFEelNrVHZESEhkU25sd1ZwblVzbEZnYko4SVd3MEhzUjNfRk93MUc2UQ?oc=5","date":"2025-12-21","type":"deal","source":"Investing.com","summary":"Jacobio Pharma signs $2 billion license deal with AstraZeneca for cancer drug - Investing.com","headline":"Jacobio Pharma signs $2 billion license deal with AstraZeneca for cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPRmtJeUh2WXNmLTJVaUEzbF9uYmxxb3JNXzhZVGp3dElmYkprR245a1pQcjc2dURGS3VkNmZwLUtWTnlOZjZ6OUZOMWhMYmFuR1RLVFBtUzU3UF94Y1Q4a09jbTZHMU94NFZyVTkwcmRKOC14eG14Ym16QmY1QnR4Mm5RQ09BUXlObE5jemNPLS1YRDBTWHZJdENBOGpfZ2RLanVFWW84YmxFN1cwSkxqT1gwbGtVQmtSWXRDamxucGxGRnlqWE03cjRaR1FMWFBVZmc?oc=5","date":"2025-10-16","type":"deal","source":"BioSpectrum Asia","summary":"Oceanpine Capital acquires 80% equity interest in Beijing Jacoray Pharma for RMB 200 M - BioSpectrum Asia","headline":"Oceanpine Capital acquires 80% equity interest in Beijing Jacoray Pharma for RMB 200 M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOUS1FV3pkd0ZBZkhKSS1jSlF5REEtNjRNZDZOX3VzX20tZEU3VUxTVmRHbm92RG9lb1hTOVlGMHJWSzhhalRzS19teXNPNndEbGNrLXhMMmZyeHM3ZmlrZGJzaU5VeWZ3VHBrWEl1WlBjbUYyVi1WdEVyQ0pMcm9xeTBB?oc=5","date":"2024-09-02","type":"pipeline","source":"Pharmaceutical Technology","summary":"Jacobio Pharma grants Allist rights to two assets in China - Pharmaceutical Technology","headline":"Jacobio Pharma grants Allist rights to two assets in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNcmVSNlRST0hraTlkMW9qVGdpMmVHQ1lQb1JSZGZFcGRZOWZmZ2owbE03eThpUFdZcnNuNklXX0V3QUVEeVEzbnF2c3R6R01yNnlJWklBUDBJT0hhdVpZa1RJcFVfdHZ1YXhpbW01MEZidHNFN19HQWZmV0NWa1NJcWtXUm95Njc0dmlFZk92UVBsUURrb2dyZ21RUnBLbmtjRkJjMzRuOFlENEtzWlN5Q1JCS0xBX2lSSi1pTENtYXpOb1RMeFZlN3ZnOFh2MDhZZXpYRGRja20zYnNzbkJrUmczUUF5Wks3WFE?oc=5","date":"2024-08-30","type":"deal","source":"prnewswire.com","summary":"Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China - prnewswire.com","headline":"Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}